What to know
Flu vaccine is produced by private manufacturers, so supply depends on manufacturers. Vaccine manufacturers projected that they will supply the United States with as many as 148 million doses of influenza vaccines for the 2024-2025 season. These projections may change as the season progresses. All flu vaccines for the 2024-2025 season will be trivalent (three component). Most of the projected flu vaccine supply will be thimerosal-free or thimerosal-reduced vaccine (94%), and about 20% of flu vaccines will be egg-free.
Total Doses Distributed
Week
Total Doses Distributed
9/14/2024
78.12M
9/21/2024
92.35M
9/28/2024
108.04M
10/5/2024
116.01M
10/12/2024
122.93M
10/19/2024
127.31M
10/26/2024
131.40M
11/2/2024
134.19M
11/9/2024
136.16M
11/16/204
138.21M
11/23/2024
139.24M
11/30/2024
139.65M
12/7/2024
142.89M
12/21/2024
144.58M
12/31/2024
144.88M
1/11/2025
145.54M
1/18/2025
145.92M
1/25/2025
146.22M
2/1/2025
146.47M
2/8/2025
146.76M
2/15/2025
147.01M
2/22/2025
147.17M
3/1/2025
147.39M
3/8/2025
147.55M
Table of 2024-25 Seasonal Influenza Vaccine — Total Doses Distributed